Hubei Biocause Heilen Pharmaceutical Co (SZSE:301211) Total Stockholders Equity : ¥2,394.9 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Hubei Biocause Heilen Pharmaceutical Co Total Stockholders Equity?

Hubei Biocause Heilen Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥2,394.9 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Hubei Biocause Heilen Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥8.32. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Hubei Biocause Heilen Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.00.

Hubei Biocause Heilen Pharmaceutical Co Total Stockholders Equity Historical Data

The historical data trend for Hubei Biocause Heilen Pharmaceutical Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Biocause Heilen Pharmaceutical Co Total Stockholders Equity Chart

Hubei Biocause Heilen Pharmaceutical Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

488.25

700.39

2,222.78

2,276.57

2,356.69

Hubei Biocause Heilen Pharmaceutical Co Quarterly Data
	Dec18	Jun19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															2,316.75	2,294.55	2,326.72	2,356.69	2,394.94

Hubei Biocause Heilen Pharmaceutical Co (SZSE:301211) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Hubei Biocause Heilen Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(2394.936	-	0)	/	288
	=	8.32

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Hubei Biocause Heilen Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.508	+	4.407)	/	2394.936
	=	0.00

Hubei Biocause Heilen Pharmaceutical Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Hubei Biocause Heilen Pharmaceutical Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Hubei Biocause Heilen Pharmaceutical Co (SZSE:301211) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Biocause Heilen Pharmaceutical Co Ltd (SZSE:301211) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

N/A

Address

No. 122, Yangwan Road, Dadao District, Jingmen High-tech Zone, Hubei Province, Jingmen, CHN, 448000

Website

http://www.biocause.com

Hubei Biocause Heilen Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical raw materials and preparation products.

Hubei Biocause Heilen Pharmaceutical Co (SZSE:301211) Headlines

No Headlines